Current Research Studies
Research studies at the Research Institute at Lindner Center of HOPE are currently being conducted for Bipolar Disorder, Major Depression and Eating Disorders.
The Research Institute at Lindner Center of HOPE conducts research regarding the biological causes and treatments for mood and eating disorders. Currently Dr. Susan McElroy is recruiting people for studies on bipolar disorder (also known as manic depression), major depression, eating disorders (binge eating disorder), and smoking cessation.
For more information about the Research Institute, contact (513) 536-0716 or click here.
If you would like to fill out a short pre-screen questionnaire for our weight loss in stable bipolar disorder study, please click here
If you would like to fill out a short pre-screen questionnaire for our depression study using non-invasive spinal stimulation, please click here.
Diagnosed With Bipolar Disorder And Overweight?
What
The purpose of this placebo controlled research study is to gather information about the effects of investigational medication on weight loss in individuals with stable Bipolar Disorder.
Who
18-65 years old men and women diagnosed with Bipolar Disorder who are obese or overweight and interested in weight loss. Must be on a stable regimen of medication for Bipolar Disorder for at least 3 months.
Pay
Study-related evaluations, tests and medication without charge. Eligible participants will be compensated $50 per visit for their time and travel.
Details
If you would like to fill out a short pre-screen questionnaire for our weight loss in stable bipolar disorder study, please click here.
For more information about the Research Institute, contact (513) 536-0710 or email Anna Guerdjikova at anna.guerdjikova@lindnercenter.org.
Do you want to quit smoking?
Lindner Center of HOPE is conducting a clinical trial of a non‐invasive, investigational medical device, Deep Transcranial Magnetic Stimulation, that may help people to quit smoking.
To be eligible you must:
- Be between the ages of 22– 70 years old
- Have smoked at least 10 cigarettes a day for over a year
- Want to quit smoking
All qualified participants will receive study related exams, lab work and treatments at no cost.
Enrolled participants will receive compensation for time and travel.
For more information, please call Anna at (513) 536-0710 or email anna.guerdjikova@lindnercenter.org.
For more information about the Research Institute, contact (513) 536-0716 or click here.
Diagnosed With Bipolar Disorder And Overweight?
What
The purpose of this placebo controlled research study is to gather information about the effects of investigational medication on weight loss in individuals with stable Bipolar Disorder.
Who
18-65 years old men and women diagnosed with Bipolar Disorder who are obese or overweight and interested in weight loss. Must be on a stable regimen of medication for Bipolar Disorder for at least 3 months.
Pay
Study-related evaluations, tests and medication without charge. Eligible participants will be compensated $50 per visit for their time and travel.
Details
If you would like to fill out a short pre-screen questionnaire for our weight loss in stable bipolar disorder study, please click here.
Non-invasive Spinal Stimulation for the Treatment of Major Depression
What
The purpose of this study is to evaluate whether the use of a small electrical current applied through the skin is useful and safe in the treatment of adults diagnosed with major
depression. Participation will last approximately 8 weeks and involve visits to the research center three times per week.
Who
Adults ages 18–50 who are currently moderately depressed for at least 1 month. Not currently on medication treatment for depression.
Pay
Eligible participants will be compensated up to $250 for their time and travel.
Details
For more information, contact Brian or George at 513-536-0707.
If you would like to fill out a short pre-screen questionnaire for our depression study, please click here.
Pediatric Tourette Syndrome (Platinum study)
What:
The primary purpose of this clinical research study is to determine the safety, tolerability, and effectiveness of an investigational medication for Tourette syndrome in children. An investigational medication is one that is not approved by the US Food and Drug Administration (FDA).
Who:
Boys and girls aged 6–17 years. Have a diagnosis of Tourette syndrome and symptoms that impair school, occupational, and/or social function. Are in good general health, as determined by medical history, physical examination, and laboratory tests.
Study schedule:
Attend a screening visit to determine your eligibility. Participation in this study will last approximately 11 months (including up to 28 days of screening), 36 weeks of dosing, and a final study visit (done 4 weeks after you take the final dose). The entire study consists of up to 17 study visits, including the screening visit.
For more information, please call (513) 536-0707 or visit https://tforceplatinum.com/ or view https://www.youtube.com/watch?v=LgJP5uzDj2I